Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Scott D. Rand MD, PhD

Scott D. Rand MD, PhD

Professor

Institution: Medical College of Wisconsin
Department: Radiology
Division: Neuroradiology
Program: General

Member of the Cancer Center


Publications

  • Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project. (Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC) AJNR Am J Neuroradiol 2018 Jun;39(6):1008-1016 PMID: 29794239 PMCID: PMC6002911 05/26/2018       1 Citations
  • Acid ceramidase and its inhibitors: a drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency. (Doan NB, Alhajala H, Al-Gizawiy MM, Mueller WM, Rand SD, Connelly JM, Cochran EJ, Chitambar CR, Clark P, Kuo J, Schmainda KM, Mirza SP) Oncotarget 2017 Dec 22;8(68):112662-112674 PMID: 29348854 PMCID: PMC5762539 01/20/2018    
  • Acid ceramidase confers radioresistance to glioblastoma cells. (Doan NB, Nguyen HS, Al-Gizawiy MM, Mueller WM, Sabbadini RA, Rand SD, Connelly JM, Chitambar CR, Schmainda KM, Mirza SP) Oncol Rep 2017 Oct;38(4):1932-1940 PMID: 28765947 PMCID: PMC5652937 08/03/2017       6 Citations
  • Acid ceramidase is a novel drug target for pediatric brain tumors. (Doan NB, Nguyen HS, Montoure A, Al-Gizawiy MM, Mueller WM, Kurpad S, Rand SD, Connelly JM, Chitambar CR, Schmainda KM, Mirza SP) Oncotarget 2017 Apr 11;8(15):24753-24761 PMID: 28445970 PMCID: PMC5421885 04/28/2017    
  • Changes in perfusion and diffusion in the endplate regions of degenerating intervertebral discs: a DCE-MRI study. (Arpinar VE, Rand SD, Klein AP, Maiman DJ, Muftuler LT) Eur Spine J 2017 05;26(5):1416 PMID: 28425065 04/21/2017    
  • Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy. (McGarry SD, Hurrell SL, Kaczmarowski AL, Cochran EJ, Connelly J, Rand SD, Schmainda KM, LaViolette PS) Tomography 2016 Sep;2(3):223-228 PMID: 27774518 PMCID: PMC5074084 10/25/2016    
  • Spinal osteoblastic meningioma with hematopoiesis: radiologic-pathologic correlation and review of the literature. (Cochran EJ, Schlauderaff A, Rand SD, Eckardt GW, Kurpad S) Ann Diagn Pathol 2016 Oct;24:30-4 PMID: 27649951 09/22/2016    
  • Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. (Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS) AJNR Am J Neuroradiol 2016 12;37(12):2201-2208 PMID: 27492073 PMCID: PMC5161572 08/06/2016       14 Citations
  • Quantifying metal-induced susceptibility artifacts of the instrumented spine at 1.5T using fast-spin echo and 3D-multispectral MRI. (Kaushik SS, Karr R, Runquist M, Marszalkowski C, Sharma A, Rand SD, Maiman D, Koch KM) J Magn Reson Imaging 2017 01;45(1):51-58 PMID: 27227824 05/27/2016       5 Citations
  • Changes in perfusion and diffusion in the endplate regions of degenerating intervertebral discs: a DCE-MRI study. (Arpinar VE, Rand SD, Klein AP, Maiman DJ, Muftuler LT) Eur Spine J 2015 Nov;24(11):2458-67 PMID: 26238936 PMCID: PMC4755697 08/05/2015       14 Citations
  • Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. (LaViolette PS, Mickevicius NJ, Cochran EJ, Rand SD, Connelly J, Bovi JA, Malkin MG, Mueller WM, Schmainda KM) Neuro Oncol 2014 Dec;16(12):1599-606 PMID: 25059209 PMCID: PMC4232087 07/26/2014       28 Citations
  • Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. (Heroux MS, Chesnik MA, Halligan BD, Al-Gizawiy M, Connelly JM, Mueller WM, Rand SD, Cochran EJ, LaViolette PS, Malkin MG, Schmainda KM, Mirza SP) Physiol Genomics 2014 Jul 01;46(13):467-81 PMID: 24803679 PMCID: PMC4587597 05/08/2014       15 Citations
  • Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. (Schmainda KM, Prah M, Connelly J, Rand SD, Hoffman RG, Mueller W, Malkin MG) Neuro Oncol 2014 Jun;16(6):880-8 PMID: 24431219 PMCID: PMC4022214 01/17/2014       62 Citations
  • The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. (Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ) J Neurooncol 2013 Sep;114(3):291-7 PMID: 23813291 07/03/2013       2 Citations
  • Effects of perfusion on diffusion changes in human brain tumors. (Cohen AD, LaViolette PS, Prah M, Connelly J, Malkin MG, Rand SD, Mueller WM, Schmainda KM) J Magn Reson Imaging 2013 Oct;38(4):868-75 PMID: 23389889 PMCID: PMC3735792 02/08/2013       3 Citations
  • Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. (LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM) Neuro Oncol 2013 Apr;15(4):442-50 PMID: 23382287 PMCID: PMC3607265 02/06/2013       32 Citations
  • Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. (Ellingson BM, LaViolette PS, Rand SD, Malkin MG, Connelly JM, Mueller WM, Prost RW, Schmainda KM) Magn Reson Med 2011 Apr;65(4):1131-43 PMID: 21413079 PMCID: PMC3065939 03/18/2011       34 Citations
  • 3D visualization of subdural electrode shift as measured at craniotomy reopening. (LaViolette PS, Rand SD, Ellingson BM, Raghavan M, Lew SM, Schmainda KM, Mueller W) Epilepsy Res 2011 Mar;94(1-2):102-9 PMID: 21334178 PMCID: PMC4329774 02/22/2011       24 Citations
  • Three-dimensional visualization of subdural electrodes for presurgical planning. (LaViolette PS, Rand SD, Raghavan M, Ellingson BM, Schmainda KM, Mueller W) Neurosurgery 2011 Mar;68(1 Suppl Operative):152-60; discussion 160-1 PMID: 21206319 PMCID: PMC4339031 01/06/2011       8 Citations
  • Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. (Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM) J Neurooncol 2011 Mar;102(1):95-103 PMID: 20798977 PMCID: PMC3033973 08/28/2010       47 Citations
  • Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. (Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM) J Magn Reson Imaging 2010 Mar;31(3):538-48 PMID: 20187195 PMCID: PMC2903058 02/27/2010       134 Citations
  • Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri. (Ellingson BM, Rand SD, Malkin MG, Schmainda KM) J Neurooncol 2010 May;97(3):419-23 PMID: 19813078 PMCID: PMC2956408 10/09/2009       12 Citations
  • Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. (Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF) Int J Radiat Oncol Biol Phys 2006 May 01;65(1):143-51 PMID: 16618577 04/19/2006       111 Citations
  • Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. (Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, Flemming K, Huston J 3rd, Insull W Jr, Morrisett JD, Rand SD, DeMarco KJ, Yuan C) J Cardiovasc Magn Reson 2005;7(5):799-808 PMID: 16353440 12/16/2005       91 Citations
  • Feasibility of in vivo, multicontrast-weighted MR imaging of carotid atherosclerosis for multicenter studies. (Chu B, Zhao XQ, Saam T, Yarnykh VL, Kerwin WS, Flemming KD, Huston J 3rd, Insull W Jr, Morrisett JD, Rand SD, DeMarco KJ, Polissar NL, Balu N, Cai J, Kampschulte A, Hatsukami TS, Yuan C) J Magn Reson Imaging 2005 Jun;21(6):809-17 PMID: 15906345 05/21/2005       24 Citations
  • Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. (Quarles CC, Krouwer HG, Rand SD, Schmainda KM) Technol Cancer Res Treat 2005 Jun;4(3):245-9 PMID: 15896079 05/18/2005       13 Citations
  • Intravoxel distribution of DWI decay rates reveals C6 glioma invasion in rat brain. (Bennett KM, Hyde JS, Rand SD, Bennett R, Krouwer HG, Rebro KJ, Schmainda KM) Magn Reson Med 2004 Nov;52(5):994-1004 PMID: 15508160 10/28/2004       51 Citations
  • Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. (Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Krouwer HG) AJNR Am J Neuroradiol 2004 Oct;25(9):1524-32 PMID: 15502131 10/27/2004       143 Citations
  • A cost-minimizing diagnostic methodology for discrimination between neoplastic and non-neoplastic brain lesions: utilizing a genetic algorithm. (Zellner BB, Rand SD, Prost R, Krouwer H, Chetty VK) Acad Radiol 2004 Feb;11(2):169-77 PMID: 14974592 02/21/2004       3 Citations
  • Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. (Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM) Neuro Oncol 2003 Oct;5(4):235-43 PMID: 14565159 PMCID: PMC1920679 10/21/2003       55 Citations
  • The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. (Pathak AP, Rand SD, Schmainda KM) J Magn Reson Imaging 2003 Oct;18(4):397-403 PMID: 14508775 09/26/2003       37 Citations
  • Noninvasive assessment of neoplastic angiogenesis: the role of magnetic resonance imaging. (Abu-Hajir M, Rand SD, Krouwer HG, Schmainda KM) Semin Thromb Hemost 2003 Jun;29(3):309-15 PMID: 12888935 07/31/2003       6 Citations
  • In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures. (Neppl R, Nguyen CM, Bowen W, Al-Saadi T, Pallagi J, Morris G, Mueller W, Johnson R, Prost R, Rand SD) AJNR Am J Neuroradiol 2001 Nov-Dec;22(10):1933-43 PMID: 11733328 12/06/2001       20 Citations
  • MRS imaging of gamma knife treatment for gliomas: from metabolite ratios to therapeutic rationale. (Rand SD, Krouwer HG) AJNR Am J Neuroradiol 2001 Apr;22(4):598-9 PMID: 11290463 04/06/2001       1 Citations
  • Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. (Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW) Magn Reson Med 2000 Jun;43(6):845-53 PMID: 10861879 06/22/2000       173 Citations
  • Applicability of American College of Radiology appropriateness criteria in a general internal medicine clinic. (Martin TA, Quiroz FA, Rand SD, Kahn CE Jr) AJR Am J Roentgenol 1999 Jul;173(1):9-11 PMID: 10397090 07/09/1999       17 Citations
  • Proton MR spectroscopy of the brain. (Rand SD, Prost R, Li SJ) Neuroimaging Clin N Am 1999 May;9(2):379-95 PMID: 10318721 05/11/1999       28 Citations
  • Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. (Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PR) AJNR Am J Neuroradiol 1998 Oct;19(9):1695-703 PMID: 9802493 11/05/1998       63 Citations
  • Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treatment decisions. (Adamson AJ, Rand SD, Prost RW, Kim TA, Schultz C, Haughton VM) Radiology 1998 Oct;209(1):73-8 PMID: 9769815 10/14/1998       40 Citations
  • Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy. (Manley TJ, Chusid MJ, Rand SD, Wells D, Margolis DA) Pediatr Infect Dis J 1998 May;17(5):433-4 PMID: 9613664 06/05/1998       5 Citations
  • Recent advances in MR spectroscopy expand its applications in neurologic disease. (Prost RW, Mark LP, Rand SD, Kim TA, Haughton VM) WMJ 1997 Nov;96(11):41-5 PMID: 9401448 12/24/1997       4 Citations
  • Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. (Rand SD, Prost R, Haughton V, Mark L, Strainer J, Johansen J, Kim TA, Chetty VK, Mueller W, Meyer G, Krouwer H) AJNR Am J Neuroradiol 1997 Oct;18(9):1695-704 PMID: 9367317 11/21/1997       86 Citations
  • Appropriateness of imaging procedure requests: do radiologists agree? (Kahn CE Jr, Michalski TA, Erickson SJ, Foley WD, Krasnow AZ, Lofgren RP, Quiroz FA, Rand SD) AJR Am J Roentgenol 1997 Jul;169(1):11-4 PMID: 9207492 07/01/1997       10 Citations
  • A Nyquist modulated echo-to-view mapping scheme for fast spin-echo imaging. (Keller PJ, Heiserman JE, Fram EK, Rand SD, Drayer BP) Magn Reson Med 1995 Jun;33(6):838-42 PMID: 7651122 06/01/1995       6 Citations
  • Three-dimensional fast spin-echo imaging: pulse sequence and in vivo image evaluation. (Yuan C, Schmiedl UP, Weinberger E, Krueck WR, Rand SD) J Magn Reson Imaging 1993 Nov-Dec;3(6):894-9 PMID: 8280980 11/01/1993       41 Citations
  • Rapid projection MRI of short T(2) species with multiple small angle excitations and oscillatory-rotary field gradients. (Rand SD, Macovski A) IEEE Trans Med Imaging 1988;7(2):99-108 PMID: 18230458 01/01/1988    
  • Rapid MRI of short t2 species with multiple small angle excitations and time-varying gradients. (Rand SD, Macovski A) IEEE Trans Med Imaging 1987;6(4):346-55 PMID: 18244044 01/01/1987    
  • Mechanisms for excited state relaxation and dissociation of oxymyoglobin and carboxymyoglobin. (Reynolds AH, Rand SD, Rentzepis PM) Proc Natl Acad Sci U S A 1981 Apr;78(4):2292-6 PMID: 6941287 PMCID: PMC319331 04/01/1981       36 Citations
  • Last update: 06/11/2018
    jenkins-FCD Prod-296 4db9d02597e0a2e889e230f853b641c12f1c3ee3